Skip to main content
PeptiDream Inc. logo

PeptiDream Inc. — Investor Relations & Filings

Ticker · 4587 ISIN · JP3836750004 T Manufacturing
Open in API
Filings indexed 72 across all filing types
Latest filing 2018-05-15 Interim / Quarterly Rep…
Country JP Japan
Listing T 4587

About PeptiDream Inc.

https://www.peptidream.com/en/

PeptiDream Inc. is a biopharmaceutical company specializing in the discovery and development of novel therapeutics, primarily macrocyclic peptides. The company utilizes its proprietary Peptide Discovery Platform System (PDPS) to generate and screen extensive libraries of non-standard peptides, aiming to create a new class of innovative medicines. Its business model is centered on global collaborations and licensing agreements with pharmaceutical partners to advance drug discovery programs from hit identification to clinical candidates. PeptiDream's capabilities encompass various preclinical research disciplines, including discovery biology, medicinal chemistry, and pharmacology. Through a wholly-owned subsidiary, the company also markets and sells radiopharmaceutical and radiodiagnostic products.

Recent filings

Filing Released Lang Actions
四半期報告書－第12期第3四半期(2018/01/01－2018/03/31)
Interim / Quarterly Report Classification · 100% confidence The document is a '四半期報告書' (Quarterly Report) filed with the Kanto Local Finance Bureau under the Financial Instruments and Exchange Act of Japan. It contains detailed financial statements, management analysis (MD&A), and corporate information for the third quarter of the 12th fiscal period (ending March 31, 2018). It is a comprehensive financial report for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report. 9M 2018
2018-05-15 Japanese
四半期報告書－第12期第2四半期(2017/10/01－2017/12/31)
Interim / Quarterly Report Classification · 100% confidence The document is a Japanese '四半期報告書' (Quarterly Report) filed with the Kanto Local Finance Bureau under the Financial Instruments and Exchange Act. It contains detailed financial statements, management analysis (MD&A), and shareholding information for the second quarter of the 12th fiscal period (ending December 31, 2017). As it is a comprehensive financial report for a period shorter than a full fiscal year, it falls under the 'Interim / Quarterly Report' category. Q2 2018
2018-02-14 Japanese
四半期報告書－第12期第1四半期(2017/07/01－2017/09/30)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) filed with the Kanto Local Finance Bureau in Japan, pursuant to the Financial Instruments and Exchange Act. It contains detailed financial statements (balance sheets, income statements, cash flow statements) and management analysis for the first quarter of the 12th fiscal period (July 1, 2017 to September 30, 2017). This fits the definition of an Interim/Quarterly Report (IR). Q1 2018
2017-11-09 Japanese
有価証券報告書－第11期(2016/07/01－2017/06/30)
Annual Report Classification · 100% confidence The document is a Japanese 'Yuka Shoken Hokokusho' (Securities Report), which is the Japanese equivalent of a 10-K. It contains comprehensive financial statements, management discussion and analysis, business overview, and corporate information for the fiscal year ending June 30, 2017. It is a formal, long-form regulatory filing submitted to the Kanto Local Finance Bureau. FY 2017
2017-09-28 Japanese
四半期報告書－第11期第3四半期(2017/01/01－2017/03/31)
Interim / Quarterly Report Classification · 100% confidence The document is a Japanese 'Quarterly Report' (四半期報告書) filed with the Kanto Local Finance Bureau under the Financial Instruments and Exchange Act. It contains detailed financial statements, including balance sheets and income statements for the third quarter, and is clearly a substantive financial report rather than an announcement or certification. Based on the provided definitions, this corresponds to an Interim/Quarterly Report (IR). 9M 2017
2017-05-15 Japanese
四半期報告書－第11期第2四半期(2016/10/01－2016/12/31)
Interim / Quarterly Report Classification · 100% confidence The document is a 'Quarterly Report' (四半期報告書) filed by PeptiDream Inc. in accordance with the Financial Instruments and Exchange Act of Japan. It contains detailed financial statements (balance sheets, income statements, cash flow analysis) for the second quarter of the 11th fiscal period (July 1, 2016, to December 31, 2016). As it provides comprehensive financial data and analysis for an interim period, it is classified as an Interim/Quarterly Report. H1 2017
2017-02-14 Japanese

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.